Skip to content
Search

Latest Stories

Research shows middle-age Covid-19 mortality risk

Middle-aged people, and not just the elderly, have a dramatically higher risk of dying or developing serious illness from Covid-19, new research from Britain showed Tuesday (31).

The findings came in a new comprehensive analysis of virus cases in mainland China.


Researchers from Britain analysed more than 3,600 confirmed Covid-19 cases as well as data from hundreds of passengers repatriated from the outbreak city of Wuhan.

They found that age was a key determining factor in serious infections, with nearly one in five over-80s requiring hospitalisation, compared to around 1 percent among people under 30.

Taking into account estimates of the number of cases that may not have been clinically confirmed - that is, mild or asymptomatic infections - the data showed the hospitalisation rate of patients in their fifties was 8.2 per cent.

The study, published in The Lancet Infectious Diseases journal, estimated that the mortality rate from confirmed Covid-19 cases in mainland China was 1.38 per cent.

If unconfirmed cases were taken into account, the death rate dropped to 0.66 per cent.

The authors of the research said that while this was significantly lower than previous estimates, Covid-19 is still several times deadlier than previous pandemic viruses, such as H1N1.

"Our estimates can be applied to any country to inform decisions around the best containment policies for Covid-19," said Azra Ghani, a study co-author from Imperial College London.

"There might be outlying cases that get a lot of media attention, but our analysis very clearly shows that at aged 50 and over, hospitalisation is much more likely than in those under 50, and a greater proportion of cases are likely to be fatal."

Billions of people have been confined to their homes around the world as governments desperately try to stop the spread of the novel coronavirus.

As of 1900 GMT Monday (30) the virus had killed 36,374 people out of 757,940 cases globally.

That would mean 4.8 per cent of all confirmed Covid-19 infections have proven deadly.

But experts stress that without widespread testing it is impossible to know how many people may have become infected and recovered.

This means the true mortality rate is likely much lower, in line with The Lancet study and previous research from China.

The Lancet study showed that 18.4 per cent of patients in their 80s were hospitalised in China.

This compared to 4.3 percent for 40 to 49-year-olds and roughly 1 percent for people in their 20s.

According to their modelling, the authors estimate that 50-80 percent of the global population could contract Covid-19 but that came with several caveats, as modelling can't account for behavioural changes such as hand washing and social distancing.

Devi Sridhar, professor and chair of Global Public Health, at the University of Edinburgh's Medical School, said that the assumption that most people would become infected was leading governments, including in Britain, to abandon measures that could help slow the pandemic.

She tweeted on Tuesday that the models "resulted in the UK giving up on containment too early & assuming everyone will get it.

"Planning & preparing for unprecedented testing & using big data/apps for tracing were taken off the table. In my view, we went down the wrong path," she said.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less